FIELD: pharmaceutical industry.
SUBSTANCE: present group of inventions relates to the pharmaceutical industry, in particular to highly efficient encapsulation of hydrophilic substances into liposomes. Unilamellar liposome (UL) with one lipid bilayer surrounding a hydrophilic space for encapsulating hydrophilic substances, containing: (i) at least one hydrophobic compound forming a lipid bilayer, and (ii) propylene glycol or glycerol, in which the hydrophilic space contains at least at least one hydrophilic compound dissolved in a hydrophilic solvent, wherein the concentration of the hydrophilic compound in the hydrophilic solvent is at least 80% of the saturation concentration of the hydrophilic compound in the hydrophilic solvent at 20 °C and 101 kPa, and wherein said UL contains at least one hydrophobic compound in an amount of 15 to 40% by weight of UL. Liquid composition containing at least one UL for encapsulating hydrophilic substances. A method for encapsulating hydrophilic compounds in UL, including certain stages. Application of UL as a drug. Application of UL as a cosmetic product. Application of UL as a food additive. Use of UL as a disinfectant. Application of the composition as a drug. Application of the composition as a cosmetic product. Application of the composition as a food additive. Application of the composition as a disinfectant.
EFFECT: providing a method for encapsulating hydrophilic compounds in the hydrophobic space of liposomes with high encapsulation efficiency.
30 cl, 9 dwg, 4 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
NEW LIPOSOME VECTORS OF ACTIVE SUBSTANCES | 1998 |
|
RU2203649C2 |
LIPOSOMAL COMPOSITIONS APPLICABLE FOR DRUG DELIVERY | 2005 |
|
RU2574926C2 |
METHOD OF PRODUCING LIPID NANOPARTICLES FOR DRUG DELIVERY | 2012 |
|
RU2647476C2 |
LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 |
|
RU2757110C2 |
DRIED RECONSTITUTED VESICLES FOR PHARMACEUTICAL APPLICATION | 2007 |
|
RU2443412C2 |
LIPOSOMAL COMPOSITION AND PREPARATION THEREOF | 2018 |
|
RU2728976C2 |
LIPOSOME FORMULATION AND ITS PREPARATION | 2013 |
|
RU2649805C2 |
PHARMACEUTICAL COMPOSITION FOR TREPOSTINIL CONTROLLED RELEASE | 2019 |
|
RU2796305C2 |
DISPOSABLE SYSTEM FOR STERILE OBTAINING OF LIPIDS AND NUCLEIC ACIDS PARTICLES | 2012 |
|
RU2642640C2 |
LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
Authors
Dates
2023-01-19—Published
2018-03-23—Filed